AstraZeneca Extends License for Linguamatics Text-Mining Software | GenomeWeb

NEW YORK (GenomeWeb News) – Linguamatics said today that AstraZeneca has extended its license for the company's I2E text-mining platform in a multi-year deal.

AstraZeneca has been a Linguamatics customer since 2003.

Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.